We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+11.7%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$334B
AUM Growth
+$44B
Cap. Flow
+$10.5B
Cap. Flow %
3.13%
Top 10 Hldgs %
13.87%
Holding
10,649
New
1,223
Increased
4,779
Reduced
2,819
Closed
1,395

Sector Composition

Rank Sector Weight
1 Technology 13.13%
2 Financials 7.1%
3 Healthcare 6%
4 Consumer Discretionary 5.02%
5 Industrials 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TOLL icon
8776
Tema Durable Quality ETF
TOLL
$57.9M
$201 ﹤0.01%
+7
New +$183
AIHS icon
8777
Senmiao Technology Ltd
AIHS
$19.8M
$200 ﹤0.01%
49
+39
+390% +$140
ML.WS
8778
DELISTED
MoneyLion Inc. Warrants, each whole warrant exercisable 1/30th of a share of Class A common stock at an exercise price of $345.00 per whole share
ML.WS
$200 ﹤0.01%
+2,003
New +$113
ZSB icon
8779
USCF Sustainable Battery Metals Strategy Fund
ZSB
$2.16M
$199 ﹤0.01%
+12
New +$211
AWX icon
8780
Avalon Holdings
AWX
$9.98M
$198 ﹤0.01%
+83
New +$170
CPIX icon
8781
Cumberland Pharmaceuticals
CPIX
$100M
$197 ﹤0.01%
+110
New +$202
TBMCR
8782
DELISTED
Trailblazer Merger Corporation I Rights
TBMCR
$197 ﹤0.01%
1,931
-12,591
-87% -$1.64K
ASCBW
8783
DELISTED
A SPAC II Acquisition Corp. Warrant
ASCBW
$197 ﹤0.01%
+39,343
New +$539
DDL
8784
Dingdong
DDL
$562M
$194 ﹤0.01%
129
-23,200
-99% -$44.1K
CSCI
8785
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$193 ﹤0.01%
26
+8
+44% +$59
POTX
8786
DELISTED
Global X Cannabis ETF
POTX
$193 ﹤0.01%
+33
New +$188
IVP
8787
DELISTED
Inspire Veterinary Partners
IVP
-1
Closed -$1.74K
BLEUU
8788
DELISTED
bleuacacia ltd Unit
BLEUU
$192 ﹤0.01%
20
-80
-80% -$852
EVAX
8789
Evaxion A/S
EVAX
$23.5M
$190 ﹤0.01%
6
-74
-93% -$2.97K
WIMI
8790
WiMi Hologram Cloud
WIMI
$22.1M
$190 ﹤0.01%
+24
New +$163
XPON icon
8791
Expion360
XPON
$3.44M
0
HIPO.WS
8792
DELISTED
Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share
HIPO.WS
$188 ﹤0.01%
9,378
+7,968
+565% +$171
KXIN icon
8793
Kaixin Holdings
KXIN
$8.76M
0
OGEN icon
8794
Oragenics
OGEN
$2.26M
$186 ﹤0.01%
1
-3
-75% -$355
CHB
8795
DELISTED
Global X China Biotech Innovation ETF
CHB
$186 ﹤0.01%
23
-1,235
-98% -$9.84K
BACA
8796
DELISTED
Berenson Acquisition Corp. I
BACA
$185 ﹤0.01%
+18
New +$185
BFIIW
8797
DELISTED
BurgerFi International, Inc. Warrant
BFIIW
$184 ﹤0.01%
4,079
-95,191
-96% -$6.3K
LIDR icon
8798
AEye
LIDR
$52.8M
$183 ﹤0.01%
80
-155
-66% -$761
CELG.RT
8799
Bristol-Myers Squibb Rights
CELG.RT
$191M
$182 ﹤0.01%
2,026
+2,016
+20,160% +$172
ALP
8800
Alpha Compute
ALP
$4.62M
$182 ﹤0.01%
5

Similar funds

UBS Group's Q4 2023 Portfolio in Review

As of Q4 2023, UBS Group held 10,649 positions worth $334B, up 15% from $290B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group deployed $10.5B of net new capital in Q4 2023, opening 1,223 new positions and adding to 4,779 existing holdings. Its largest new stake was Veralto: 498,566 shares worth $41M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $503M trimmed.

  • UBS Group's largest Q4 2023 buy was Veralto: 498,566 shares worth $41M.
  • UBS Group added most to UBS Group in Q4 2023, an estimated $591M increase.
  • UBS Group's biggest Q4 2023 reduction was Invesco QQQ Trust, cutting an estimated $503M.
  • UBS Group fully exited Activision Blizzard in Q4 2023, selling an estimated $370M.
  • UBS Group's ten largest holdings make up 14% of its $334B portfolio in Q4 2023.
  • UBS Group opened 1,223 new positions and closed 1,395 in Q4 2023.
  • UBS Group's portfolio value rose 15% quarter-over-quarter to $334B.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.